Clinical Trial Update: The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for EVARREST in pediatric liver and soft tissue bleeding completed, with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage
• Hepatic Parenchyma Bleeding
• Soft Tissue Bleeding

Drugs mentioned

• EVARREST (fibrin sealant patch)

Snippet

Sponsor: Ethicon, Inc. | Conditions: Hemorrhage, Soft Tissue Bleeding | Phase 3 | Status: COMPLETED | Results posted: 2023-09-08